Skip to main content
Caplight Logo









Stero Biotechs

Stero Biotechs

Private
Bnei BrakHealthcare & Life Scienceshttps://sterobiotechs.com/

Last Round

Seed

Feb 1, 2017

Total Funding Raised

$1M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Stero Biotechs is a clinical-stage pharmaceutical company that develops novel cannabidiol (CBD)-based treatment solutions to reduce the side effects and necessity of steroid therapy.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

cannabidiolCBDsteroid-sparingautoimmune disease treatmentinflammatory disease treatmentclinical-stage biotechdrug developmenttherapeutic formulationcannabinoid medicinemedical cannabispharmaceutical R&Dsteroid toxicity reductionbiotech licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Stero Biotechs Comparables

Compare Stero Biotechs with similar companies based on industry and business-model similarity.

Stero Biotechs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Canurta Inc.
78%
Incannex Healthcare Inc.
64%
Incyte Corporation
56%

Stero Biotechs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 1, 2017

Stero Biotechs Investors

Notable investors and investment history

Stero Biotechs investors
InvestorRounds
Mor Research ApplicationsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 19, 2026

    Monthly visitors increased 84% MoM.

  • May 14, 2026

    Monthly visitors increased 92% MoM.

Stero Biotechs Filings

Explore SEC and related filing metadata, where available.

Stero Biotechs filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Stero Biotechs's valuation, stock price, and market status.

Is Stero Biotechs a public or private company?

Stero Biotechs is a private company.

What is the current stock price of Stero Biotechs?

Stero Biotechs is a private company with no public stock price. No recent secondary market data is available.

How much is Stero Biotechs worth (valuation)?

Valuation information for Stero Biotechs is not publicly available.

Can I buy Stero Biotechs stock?

Stero Biotechs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Stero Biotechs's last funding round?

Stero Biotechs's most recent funding round was Seed on February 1, 2017.

Who are the main investors in Stero Biotechs?

Key investors in Stero Biotechs include Mor Research Applications.

Will Stero Biotechs IPO soon?

No public IPO plans have been announced for Stero Biotechs.

How can I track Stero Biotechs secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Stero Biotechs's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBnei Brak
Employee Range1
Year Founded2017
Last FundingFeb 1, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?